Products and Services

Products and Services

Active pharmaceutical ingredients under development


Ausun

Product Name

CAS Number

Specification

TP

DMF

Status

1-(Perfluorohexyl)octane

133331-77-8

Q42025

Q2 2026

Acalabrutinib

1420477-60-6

Q42025

Q22026

Alpelisib

1217486-61-7

Q42025

Q22026

Anagliptin

739366-20-2

Q3 2025

Q1 2026

Apalutamide

Apalutamide

Q3 2025

Q1 2026

Avapritinib

1703793-34-3

Q42025

Q22026

Beraprost sodium

88475-69-8 88430-50-6 (acid)

Q4 2025

Q2 2026

Capmatinib

1029712-80-8

Q4 2025

Q2 2026

Carboprost Tromethamine

58551-69-2

Q4 2025

Q2 2026

Clazosentan

180384-56-9

Q3 2025

Q1 2026

Darolutamide

1297538-32-9

Q4 2025

Q2 2026

Deucravacitinib

1609392-27-9

Q4 2025

Q2 2026

Deutivacaftor

1413431-07-8

Q1 2026

Q3 2026

Elafibranor

923978-27-2

Q2 2026

Q1 2027

Elagolix sodium

832720-36-2

Q1 2026

Q3 2026

Elexacaftor

2216712-66-0

Q1 2026

Q3 2026

Encorafenib

1269440-29-0

Q4 2025

Q2 2026

Etrasimod

1206123-37-6

Q4 2025

Q2 2026

Fedratinib

936091-26-8

Q4 2025

Q2 2026

Finerenone

1050477-31-0

Q4 2025

Q2 2026

< 123 >